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Lactoferrin (Lt)  1  is a glycoprotein  which, like transferrin (Tf), reversibly  binds 
two ferric ions with the incorporation of two molecules of bicarbonate. These two 
proteins have a  mol wt of 76,000 and are clearly related by their amino acid 
sequence (1-6).  Also both  proteins display a  clear bacteriostatic activity by 
depriving the medium of the iron necessary for the growth of bacteria (7-9). 
However, Lf and Tf  differ on several points. They fail to show any immunolog- 
ical cross-reaction unless denatured (10). Further, the affinity of Lf for iron is 
largely retained at  pH  values below 4.0, whereas under such conditions Tf 
completely releases its iron (1-3). 
Tf is a plasma protein which is synthesized mainly in the liver (11). Lf occurs 
in the plasma only in trace amounts (12, 13) but abounds in external secretions 
(14) and specific granules of neutrophils (15, 16). Yet another difference resides 
in the ability of Tf to combine with the membrane of reticulocytes which possess 
a receptor specific for Tf (17), which is inaccessible to Lf (18). In a previous paper 
(19), we have shown that Lf has a particular affinity for the reticuloendothelial 
system (RES),  and that this property could explain the involvement of this 
protein in the hyposideremia of inflammation. 
The present work provides experimental data suggesting the existence of a 
specific receptor for Lf on mouse peritoneal cells (MPC) and, more particularly, 
on macrophages. Ideally a  study of interaction of protein and cells from one 
species would provide the best experimental model. However, the difficulties of 
obtaining sufficient amounts of both protein and cells from the same species 
imposed on us the heterologous system of human Lf and mouse cells. 
Materials and Methods 
Reagents.  Human Lf was isolated from milk by chromatography on carboxymethyl Sephadex 
(5).  Somes batches were prepared after saturation of the protein (FeLt) by adding ferric citrate in 
the presence of bicarbonate (4).  One sample was isolated in a  form poor in iron (18% saturation 
calculated from the absorbance at 460 nm).  The latter sample will be referred to  as apoLf.  A 
sample of FeLf was deprived of its iron by dialysis against 0.1 M citric acid (5). 
Human Tf devoid of iron was obtained from Behring-Institut, Marburg/Lahn,  W.  Germany. 
Human IgG was prepared from a pool of normal sera by precipitation with Rivanot (6,9-diamino- 
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acridine lactate provided by Federa, Brussels). A sample of IgG was aggregated by heating a 1% 
solution at 63°C for 30 min. Beef heart cytochrome c was purchased from Sigma Chemical Co., St. 
Louis, Mo. Ficoll was provided by Pharmacia Fine Chemicals, Uppsala, Sweden, and Isopaque by 
Nyegaard & Co., Oslo, Norway. 
Cells.  Peritoneal cells were collected according to the procedure of Cohn and Benson (20). A 
vol of 4 ml basal medium of Eagle (BME)  containing 2 mg/ml heparin was injected into the 
peritoneal cavity of NMRI female mice weighing about 30 g,  and reaspirated after abdominal 
kneading. On the average, 5 × 108 MPC were harvested from one animal. They consisted of about 
70% macrophages and 30% lymphocytes. 
Suspensions of mouse spleen cells in BME were centrifuged on a Ficoll Isopaque mixture (p = 
1,077) for 40 min at 400g. After centrifugation, the cells present at the interface between the Ficoll 
Isopaque and the medium were washed twice in BME and finally resuspended in BME containing 
1% bovine serum albumin (BSA, provided by Calbiochem, San Diego, Calif.) before incubation 
with FeLf. These cells consisted of more than 90% lymphocytes. L1210 mouse lymphoma cells are 
maintained in culture in our laboratory. 
Methods.  Succinylation of FeLf was carried out by treating 50 mg protein in 3 ml of 0.2 M 
NaC1 and 0.1 M NaHCO3 with 25 mg of succinic anhydride at room temperature for 1 h. The pH 
was maintained at 8.5 by addition of 0.1 M NaOH. 
For carbamylation, 10 mg FeLf was incubated in phosphate-buffered saline, pH 7.2,  at 45°C 
with  1 M  potassium cyanate.  Various samples of FeLf differing by their degree of chemical 
modification were prepared by changing the time of incubation. The reaction was stopped by 
passing the reagents through a column of Sephadex G-25. 
To remove neuraminic acid from FeLf, 50 mg protein dissolved in 5 ml of sodium acetate buffer 
was incubated at 37°C for 48  h  with 500  U  of neuraminidase from Vibrio cholerae (Behring- 
Institut). The solution was then dialyzed for 24 h  against 0.05 M ammonium bicarbonate, and 
lyophilized. Previous experiments (21) had  shown  that  after such  a  treatment no sialic acid 
remained on FeLf. This solution will be referred to as NANA-free FeLf. 59FeLf and 59FeTf were 
prepared by adding SSFe-citrate  to the apoproteins, in the presence of bicarbonate, up to about 80% 
of their binding capacities. Tf and Lf were iodinated with carrier-free 'zsI using the chloramine T 
technique (22). Free iodine was separated from the protein by gel filtration on Sephadex G-25. 
Iodine-labeled  proteins were.stored at -20°C. 
In  the first  experiments, the amount of  protein bound by the cells  was calculated  according to 
the  method of  Arend and Mannik (23),  where cells  were repeatedly washed and corrections  made 
for  nonspecific  adsorption.  However, in  our experiments with Lf, ai~r having applied the Arend 
and Mannik method, we  realized  that  only  a single  washing of  the  pellet  and  the  tube  without  cells 
followed by substraction of  the counts detected in the tubes without MPC  were required. There- 
fore,  in further experiments, the amount of  Lf  specifically  bound to  MPC  was determined by this 
simplifed method. 
Results 
Kinetics of LfBinding to MPC.  Peritoneal cells were incubated at 37°C with 
'2sI- or 59Fe-labeled FeLf in BME containing  1% BSA. At various time intervals, 
the reaction was stopped by diluting the reagents  10 times with BME containing 
BSA. The cells were immediately  centrifuged at 100 g  for 5 rain at 4°C,  and the 
radioactivity  of the  pellet  counted  (Fig.  1).  After  30  rain,  the  binding  curve 
tended to flatten. No significant difference in the binding was observed between 
the 5SFe- or '2~I-labeled preparations. 
To see whether  FeLf was adsorbed onto the membranes  or ingested, the cells 
were  incubated  for  30  min  at  either  37°C  or  4°C  with  ~9FeLf  (Fig.  2).  No 
significant difference was observed, suggesting that the protein was only bound 
to the cell membrane. 
Binding of  Lf to MPC as a Function of  Lf Concentration.  In a  series of seven 
experiments,  5SFeLf was added in increasing amounts  to MPC and incubated  at 
37°C for 30 min.  Aider centrifugation  and washing,  the radioactivity was mea- 1570  THE  BINDING  OF  LACTOFERRIN  TO  PERITONEAL  CELLS 
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Fro.  1.  Binding of 59FeLf to MPC as a function of time. Each point represents the mean of 
three experiments. 
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Fro.  2.  Binding of FeLf to MPC at 37°C  or 4°C.  Each point represents the mean of three 
experiments. 
sured in the pellet and the results corrected for the residual amount of free FeLf 
contaminating the cells. MPC were saturated with FeLf when its concentration 
in the medium reached,  on the average,  300 izg/ml (Fig.  3). 
A  similar experiment was performed with '25I-labeled human Tf, which was 
half-saturated with iron. No binding to MPC was observed. 
The Inhibition of Binding of FeLf to MPC.  To study the specificity  of the 
binding of FeLf to MPC,  we have compared the amount of ~gFe- or 12SI-labeled 
FeLf bound to the cells after their incubation with various proteins at different J.  L.  VAN  SNICK  AND  P.  L.  MASSON  1571 
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FIG.  3.  Saturation curve of MPC with increasing amounts of FeLf. Each point represents 
the mean of seven experiments and the vertical bar, one standard deviation. 
concentrations. MPC were preincubated with the potential inhibitor at 4°C for 
15 min in BME containing 1% BSA. Then, 500 ~g of  radioactive FeLf was added, 
and the incubation prolonged for another 30 min. The percent of inhibition was 
plotted vs.  the concentration of the competitive protein (Fig.  4).  At the same 
concentration of both reagents, unlabeled FeLf inhibited by 50% the binding of 
radioactive FeLf. Human IgG did not interfere significantly. NANA-free FeLf 
displayed an inhibitory activity clearly higher than native FeLf. 
A  second series of inhibition  experiments was  carried out using only one 
concentration of the competitive protein,  i.e.,  500  ~g/ml  (Table I).  ApoLf in- 
hibited the binding of radioactive FeLfto a lower extent than did cold FeLf. The 
difference was at the limit of statistical significance (0.05  < P  <  0.10).  Surpris- 
ingly, when the sample of Lf which was deprived of its iron by dialysis against 
citric acid was used,  no inhibition was observed.  Furthermore, no inhibitory 
activity was recovered even when iron was added to this Lf sample, of which the 
iron saturation was shown by the reappearance of  the characteristic pink hue. 
After succinylation or carbamylation, Lf retained its iron as shown by its 
absorbance  spectrum.  However,  the  protein  lost  its  inhibitory  activity as  a 
reciprocal function of its chemical modification. Various samples of carbamy- 
lated FeLf were analyzed in electrophoresis in agarose gel at pH 8.6 together 
with native FeLf and sialic acid-free FeLf. When the inhibitory activity of each 
preparation was plotted vs. their electrophoretic mobility, a linear relationship 
was observed (Fig. 5), indicating that the affinity of FeLf for mouse peritoneal 
cells decreased with the suppression of positive electric charge of the protein. 
However, a protein with a high isoelectric point such as beef  heart cytochrome  c 
(pI =  10.6,  reference 24) failed to inhibit the binding of FeLf. 1572  THE  BINDING  OF  LACTOFERRIN  TO  PERITONEAL  CELLS 
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FIG.  4.  Inhibition of the binding of t25I-labeled  FeLf to MPC by various human proteins. 
Each point represents the mean of three experiments. 
TABLE  I 
Inhibition  of the Binding  of Radioactive  FeLf to MPC by Various 
Proteins 
Competitive protein 
Percent of  inhibition (Mean ± SD) 
59Fe-labeled FeLf  125I-labeled FeLf 
FeLf 
ApoLf 
Fe-deprived Lf 
Fe-resaturated Lf 
NANA-free FeLf 
Succinylated FeLf 
Carbamylated FeLf* 
1 min 
5 min 
10 rain 
30 min 
FeTf 
Human IgG 
Human aggregated IgG 
Beef heart cytochrome c 
46.4  ±  7.4  (13)  46.0  ±  8.1  (6) 
28.2  ±  4.9 (3) 
No inhibition (3) 
No inhibition (3) 
53.0  ±  8.3  (4)  66.6-62.8 
No inhibition (4) 
40.8  ±  2.4  (4) 
31.7  +- 2.0  (4) 
20.0  -+ 5.2  (4) 
No inhibition 
9.1  -  5.8  (5) 
No inhibition 
No inhibition 
No inhibition 
(4) 
14.7-14.9 
(4)  6.6  ±  2.4  (3) 
(5) 
(4) 
The figures in parenthesis correspond to the number of experiments. 
* The  time  mentioned refers  to  the  incubation  of FeLf with  KCNO  (see 
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FIG.  5.  Relationship between the inhibition of the binding of 125I-labeled FeLf or 59FeLf to 
MPC by cold FeLf or carbamylated FeLf, and the relative electrophoretic mobilities of these 
samples in agarose gel at pH 8.6.  These relative mobilities were calculated by dividing the 
migration distance of the competing protein by that of human serum albumin.  For carba- 
mylation, FeLf was incubated with KCNO for increasing times. C1 FeLf corresponds to l- 
rain incubation,  C5 FeLf to 5 rain, C1o FeLf to 10 rain, and C3o FeLfto 30 rain. Each point 
represents the mean of four experiments and the vertical bars,  one standard  deviation. 
To confirm that apoLf had a lower affinity towards the peritoneal cells than 
FeLf, the experiments of competition between FeLf and apoLf were resumed 
using two kinds of labeled reagents, i.e., 59FeLf- and 125I-labeled apoLf (Table 
II). 75% inhibition of 125I-apoLfbinding was obtained with FeLl. This result was 
significantly higher than the 51.6% inhibition resulting from the preincubation 
with apoLf (0.001 < P  <  0.01). ApoLf inhibited the binding of 59FeLf  at a rate of 
32.2%, whereas cold FeLf reached 56.3%. This difference was also significant 
(0.02 < P  <  0.05). 
Comparison of the Binding of  FeLf  to Various Mouse Cells.  ~25I-labeled  FeLf 
was added in constant concentration (100 ~g per ml) to an increasing number of 
mouse cells from different origins, i.e. peritoneal cells, isolated spleen lympho- 
cytes, and L1210 lymphoma cells.  The radioactivity associated with the pellet 
was calculated after washing and appropriate corrections (see Materials and 
Methods).  A  linear relationship  was  observed between the  amount of cell- 
associated Lf and the number of cells (Fig.  6).  The slopes that indicated the 
number of FeLf molecules bound per cell differed widely depending on the type 1574  THE  BINDING  OF  LACTOFERRIN  TO  PERITONEAL  CELLS 
TABLE  II 
Inhibition of the Binding of '25I-apoLf or 59FeLf to MPC by 
apoLf and FeLf 
Competitive protein 
Percent of inhibition 
125I-apoLf  59Fe-Lf 
% 
APOLf  51.6  _  4.9  (5)  32.2  -+ 4.3  (5) 
FeLf  75  _+  2.3  (5)  56.3  -+  7.3  (4) 
The figures in parentheses correspond  to the number of experiments. 
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Fro.  6.  Relationship between the amount of Lf associated with MPC, spleen lymphocytes, 
and L1210 cells, and the number of cells exposed to the protein. 
of cells studied.  The peritoneal  cells bound much more FeLf than  did spleen 
lymphocytes or L1210 lymphoma cells. 
As a control, sheep and human red blood cells were incubated with the same 
preparation of 125I-labeled FeLf under identical conditions. No binding at all was 
detected with these cells. 
The Parameters of the Binding of  Lf to Peritoneal Macrophages  and Lympho- 
cytes.  The  MPC  were fractionated  on  a  column  of glass  beads  in  order  to 
separate the macrophages from lymphocytes. The macrophages, which adhered 
to the glass, were recovered by elution with 10 mM Na-EDTA in balanced salt 
solution  without  Ca  ++  and  Mg ÷+.  The  viability  of these  macrophages  was J.  L.  VAN  SNICK  AND  P.  L.  MASSON  1575 
checked by trypan blue exclusion. On the average, 20% of these cells were dead, 
whereas less than 4% of the lymphocytes that freely passed through the column 
failed to exclude the dye.  Owing to the poor yield of viable macrophages,  the 
study of the parameters of Lf binding was restricted to unfractionated MPC and 
to  purified  peritoneal  lymphocytes.  Knowing  the  quantity  of Lf that  these 
lymphocytes could retain, it was possible to calculate the quantity of Lfbound to 
the other cells constituting the MPC, i.e., the macrophages (Fig. 7). About 10% 
of FeLf was bound to lymphocytes. 
A Schatchard plot was constructed for the binding of 125I- of 59Fe-labeled FeLf 
to lymphocytes and macrophages  (Table III and Fig. 8). The experiments were 
carried out on the same cells, with a mixture of 125I- and 59Fe-labeled FeLf. No 
significant difference was observed between the affinity constant of FeLf toward 
macrophages or lymphocytes whatever the mode of labeling the proteins. How- 
ever, the macrophages bound approximately three times more Lf than did the 
lymphocytes. 
Discussion 
The present work has shown that human Lfcombines with the membranes of 
various  mouse  cells:  macrophages,  lymphocytes,  and  L1210  lymphoma  cells. 
Because  of the  important  role of macrophages  in iron metabolism,  we  have 
studied mainly the interaction of Lf with these cells. 
The  existence  of a  specific  receptor  for  Lf on  the  membrane  of MPC  is 
supported by the following data. 
U~ 
.J 
/ 
Iii 
(9 
Iii 
"r 
E- 
>- 
m 
(3  A 
z7 
O  +; 
>-  (k 
I-  u 
> 
}- 
(J 
O 
(3 
n, 
3 
2 
MPL 
I  1 
0.05  0,1 
FeLl  IN  THE  MEDIUM  (rag/mr) 
FIG.  7.  Saturation curves of MPC and isolated mouse peritoneal lymphocytes (MPL) with 
increasing  amounts  of  FeLf.  The  saturation  curve  of  mouse  peritoneal  macrophages 
(MPMcP)  was obtained by subtracting the curve of MPL from that of MPC. 1576  THE  BINDING  OF  LACTOFERRIN  TO  PERITONEAL  CELLS 
TABLE  III 
Number of  Molecules (N) of 12sI- or 59Fe-Labeled FeLf  Bound to Mouse Peritoneal Lymphocytes 
or Macrophages, and the Affinity Constant (K) of This Association 
~2~I-FeLf  ~gFeLf 
Cells 
Number of ex-  K  N  Number of ex-  K  N 
perimente*  10  ~ liters/tool  10  ~ per celt  perimente*  l0  s liters/tool  10  ~ per cell 
Macrophages  7  0.67 ± 0.14  22.1 ± 6.2  5  0.93 ± 0.15  17.5 ±  2.1 
Lymphocytes  3  0.95 ±  0.51  6.94 +-  2.49  5  1.06 ±  0.42  5.65 -  2.55 
* Each experiment consisted of 15 different determinations performed on a pool of MPC. 
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FIG.  8.  Schatchard  plot  (r/c  =  nK  -  rK)  of the  binding  of FeLf to  mouse  peritoneal 
macrophages. The molecules of Lf adherent to one cell (r) and the molecules of Lf free in the 
medium (c) were calculated using a mol wt of 76,000 for Lf. The value n, or the X-intercept, 
represents the number of receptors per cell, assuming one Lfmolecule occupies one receptor 
site. The slope of the line, K, represents the effective association constant in liters/tooL 
(a) The binding of FeLf to MPC reached a  saturation point, which suggests 
that these cells possess a restricted number of binding sites. 
(b) Other proteins such as human Tf, human aggregated as well as nonaggre- 
gated IgG, and beef heart cytochrome c failed to inhibit the binding of radioac- 
tive FeLf by MPC, whereas the reaction was inhibited by cold FeLf. 
(c) The integrity of the structure of Lf was critical for its reaction with MPC. 
Succinylation,  carbamylation,  and even  dialysis  against  0.1  M  citric  acid  re- 
sulted  in  a  marked  decrease  in the  affinity  of the protein  for the  cells.  This 
property of FeLf to combine with the cell membrane is much more sensitive to 
structural  changes  than  the  ability  of the  protein  to  bind  iron  since,  after 
dialysis  against  citric  acid,  the  protein  was  still  able  to  bind  iron,  but the J.  L.  VAN  SNICK  AND  P.  L.  MASSON  1577 
complex failed to react with MPC. Similar observations were reported by Schade 
(25) when he studied the combination of Tf with the membrane of reticulocytes. 
This author noticed that certain samples of Tf easily lost their ability to react 
with reticulocytes while keeping their iron-binding capacity. Further experi- 
ments with carbamylated FeLf and NANA-free FeLf  revealed the importance of 
the electric charge of the protein for its binding to MPC.  It is known that Lf 
tends to form complexes with many acidic molecules such as agaropectin, trypan 
blue (26), and albumin (27). Hence, the high isoelectric point (pI = 9.0) of Lf (21) 
could in part account for the reaction of FeLf with MPC. However, basic nature 
of the protein is not the only requirement for binding, since beef heart cyto- 
chrome c, which has a pI of 10.6 (24), did not inhibit the binding of FeLf. 
(d) The ability of apoLf to inhibit the binding of FeLf to MPC was signifi- 
cantly lower than that of FeLf. This could be explained by the steric changes 
that Lf undergoes when it combines with iron. The molecule of FeLf is more 
compact and more asymetric than that of APOLf (5). 
(e) Both sheep and human red blood cells did not bind Lf, whereas lympho- 
cytes and leukemic cells were capable of  binding Lf, albeit to a lower extent than 
do macrophages (Fig. 6 and 7). Peritoneal macrophages were found to bind on 
the average 20 × 106 molecules of FeLf  per cell, whereas peritoneal lymphocytes 
bound only 6.7  x  106 molecules per cell. The calculated values for the affinity 
constants of Lf for macrophages and lymphocytes (0.9 ×  l0  s liters/mol is of the 
same order of magnitude as the affinity constant of monomeric IgG for macro- 
phages (23). However, the numbers of bound IgG molecules is 10 times lower 
than that of Lf molecules. Apparently, there is no relationship between the Fc 
and Lf receptors of macrophages, since monomeric as well as aggregated IgG 
failed to inhibit the binding of Lf. 
The present work confirms and extends our previous observations that FeLf 
has a high affinity for the membrane of macrophages (18, 19). Previous experi- 
ments had shown that human Lf which was injected into rats was quickly 
removed by the RES with a clearance rate dependent upon the iron content of 
the  protein  and  its  structural  integrity.  The  plasma  half-life of apoLf was 
significantly prolonged, as well as that of succinylated FeLf, when compared to 
that of intact FeLf. Furthermore, after blockade of  the RES, the half-life of FeLf 
was markedly increased. 
The presence of a Lf receptor on macrophages is of interest as it could explain 
certain features of iron metabolism, particularly the hyposideremia of inflam- 
mation. This phenomenon is classically explained by the impairment of the 
reutilization of iron from hemoglobin catabolized in the RES. There is appar- 
ently a blockade in the release of iron from the RES. Fillet et al. (28) have shown 
that, in dogs, after the catabolism of hemoglobin in the RES, the iron returns to 
the plasma via two pathways, one very fast (tl/2, 24 min) and the other very slow 
(tl/2, 7 days). These pathways are of equal magnitude in normal animals, while 
in an acute inflammatory reaction there is a marked increase in the proportion 
of iron  processed through the  slow pathway.  We  propose  that  Lf,  which is 
released from neutrophils,  is  adsorbed onto the  membrane of macrophages. 
There it takes the iron released from these cells and immediately the FeLf 
complex is  reintroduced into the  RES  where it  accumulates in the  form of 1578  THE  BINDING  OF  LACTOFERRIN  TO  PERITONEAL  CELLS 
ferritin,  as will be described elsewhere.  This  storage could correspond to the 
slow pathway described by Fillet et al.  (28). 
The presence of Lf on the membrane of macrophages must also be considered 
in the light of the ability of this protein to inhibit  the growth of bacteria by 
competing for the iron necessary for bacterial development (7, 8). This activity, 
which is common to Lf and Tf, would be reinforced in the presence of antibodies 
(9). At present no role can be attributed to the binding of Lf to lymphocytes. 
Summary 
Human  iron-saturated  Lf (FeLf),  which  was labeled with  125I or 59Fe, was 
found to combine with the membrane  of mouse peritoneal  cells (MPC) which 
consisted of 70% macrophages.  The following experimental data suggested the 
involvement of a  specific receptor.  (a) The binding of FeLf to MPC reached a 
saturation point.  (b) The binding of radioactive FeLf was inhibited by preincu- 
bating the cells with cold FeLf but not with human Tf, human aggregated and 
nonaggregated IgG, or beef heart cytochrome c. (c) Succinylation and carbamy- 
lation  of FeLf resulted  in  a  loss of its  inhibiting  activity on  the  binding  of 
radioactive FeLf. Removal of neuraminic acid from FeLf increased its inhibitory 
activity.  (d)  The  ability of apoLf to inhibit  the binding  of FeLf to MPC  was 
significantly lower than that of FeLf. 
The  existence  of a  Lf receptor  capable  of concentrating  Lf released  from 
neutrophils on the membrane of macrophages could explain the apparent block- 
ade of the release of iron from the reticuloendothelial system, which accounts for 
the hyposideremia of inflammation. A receptor for FeLfwas also found on mouse 
peritoneal lymphocytes. The affinity constant of FeLf for both lymphocytes and 
macrophages was 0.9 x  106 liters/mol. However, macrophages bound three times 
more FeLf molecules (20  x  106) per cell than did lymphocytes (7  x  106). 
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